Intracellular Fixed Asset Turnover from 2010 to 2025

ITCI Stock  USD 131.70  0.05  0.04%   
Intracellular's Fixed Asset Turnover is decreasing with stable movements from year to year. Fixed Asset Turnover is estimated to finish at 47.99 this year. For the period between 2010 and 2025, Intracellular, Fixed Asset Turnover quarterly trend regression had mean deviation of  21.25 and range of 53.5101. View All Fundamentals
 
Fixed Asset Turnover  
First Reported
2010-12-31
Previous Quarter
45.70703545
Current Value
47.99
Quarterly Volatility
23.07569931
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Intracellular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intracellular's main balance sheet or income statement drivers, such as Interest Expense of 8.9 M, Total Revenue of 714.9 M or Gross Profit of 655.1 M, as well as many indicators such as Price To Sales Ratio of 12.02, Dividend Yield of 0.0 or PTB Ratio of 7.71. Intracellular financial statements analysis is a perfect complement when working with Intracellular Valuation or Volatility modules.
  
Check out the analysis of Intracellular Correlation against competitors.

Latest Intracellular's Fixed Asset Turnover Growth Pattern

Below is the plot of the Fixed Asset Turnover of Intracellular Th over the last few years. It is Intracellular's Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intracellular's overall financial position and show how it may be relating to other accounts over time.
Fixed Asset Turnover10 Years Trend
Pretty Stable
   Fixed Asset Turnover   
       Timeline  

Intracellular Fixed Asset Turnover Regression Statistics

Arithmetic Mean22.31
Geometric Mean2.90
Coefficient Of Variation103.43
Mean Deviation21.25
Median14.89
Standard Deviation23.08
Sample Variance532.49
Range53.5101
R-Value(0.21)
Mean Square Error545.06
R-Squared0.04
Significance0.43
Slope(1.02)
Total Sum of Squares7,987

Intracellular Fixed Asset Turnover History

2025 47.99
2024 45.71
2023 31.85
2022 14.89
2021 3.62
2020 0.86

About Intracellular Financial Statements

Investors use fundamental indicators, such as Intracellular's Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Although Intracellular's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Fixed Asset Turnover 45.71  47.99 

Currently Active Assets on Macroaxis

When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:
Check out the analysis of Intracellular Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.72)
Revenue Per Share
6.602
Quarterly Revenue Growth
0.508
Return On Assets
(0.07)
Return On Equity
(0.09)
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.